Cargando…

Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses

Broadly protective vaccines against SARS-related coronaviruses that may cause future outbreaks are urgently needed. The SARS-CoV-2 spike receptor-binding domain (RBD) comprises two regions, the core-RBD and the receptor-binding motif (RBM); the former is structurally conserved between SARS-CoV-2 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinnakasu, Ryo, Sakakibara, Shuhei, Yamamoto, Hiromi, Wang, Po-hung, Moriyama, Saya, Sax, Nicolas, Ono, Chikako, Yamanaka, Atsushi, Adachi, Yu, Onodera, Taishi, Sato, Takashi, Shinkai, Masaharu, Suzuki, Ryosuke, Matsuura, Yoshiharu, Hashii, Noritaka, Takahashi, Yoshimasa, Inoue, Takeshi, Yamashita, Kazuo, Kurosaki, Tomohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641255/ https://www.ncbi.nlm.nih.gov/pubmed/34623376 http://dx.doi.org/10.1084/jem.20211003

Ejemplares similares

Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees
por: Inoue, Takeshi, et al.
Publicado: (2022)

CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes
por: Onodera, Taishi, et al.
Publicado: (2023)

Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine
por: Takano, Tomohiro, et al.
Publicado: (2022)

SARS-CoV-2-specific CD4(+) T cell longevity correlates with Th17-like phenotype
por: Terahara, Kazutaka, et al.
Publicado: (2022)

Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain
por: Takano, Tomohiro, et al.
Publicado: (2023)

A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
por: Onodera, Taishi, et al.
Publicado: (2021)

Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir
por: Shinada, Kanako, et al.
Publicado: (2022)

SARS-CoV-2 Omicron-neutralizing memory B-cells are elicited by two doses of BNT162b2 mRNA vaccine
por: Kotaki, Ryutaro, et al.
Publicado: (2022)

Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients
por: Lu, Xiuyuan, et al.
Publicado: (2021)

Humoral immunity for durable control of SARS-CoV-2 and its variants
por: Kotaki, Ryutaro, et al.
Publicado: (2023)

High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection
por: Fujisawa, Mizuki, et al.
Publicado: (2023)

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
por: Moriyama, Saya, et al.
Publicado: (2021)

Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
por: Moriyama, Saya, et al.
Publicado: (2023)

Distinct germinal center selection at local sites shapes memory B cell response to viral escape
por: Adachi, Yu, et al.
Publicado: (2015)

Generation of High Quality Memory B Cells
por: Inoue, Takeshi, et al.
Publicado: (2022)

Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
por: Miyamoto, Sho, et al.
Publicado: (2023)

Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
por: Aoyama, Michihiko, et al.
Publicado: (2019)

Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
por: Takeshita, Masaru, et al.
Publicado: (2022)

Concerted hinge motions in SARS-CoV-2 spike modulated by glycan-glycan and glycan-lipid interactions
por: Kapoor, Karan, et al.
Publicado: (2022)

Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene
por: Takada, Kosuke, et al.
Publicado: (2023)

Saliva as a useful tool for evaluating upper mucosal antibody response to influenza
por: Tsunetsugu-Yokota, Yasuko, et al.
Publicado: (2022)

Exit from germinal center to become quiescent memory B cells depends on metabolic reprograming and provision of a survival signal
por: Inoue, Takeshi, et al.
Publicado: (2020)

Fluorescent glycan fingerprinting of SARS2 spike proteins
por: Wu, Zhengliang L., et al.
Publicado: (2021)

Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid
por: Yamamoto, Yuichiro, et al.
Publicado: (2022)

SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals
por: Yoshida, Shota, et al.
Publicado: (2021)

Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction
por: Torii, Shiho, et al.
Publicado: (2021)

Binding of the SARS-CoV-2 spike protein to glycans
por: Hao, Wei, et al.
Publicado: (2021)

The roles of glycans in the SARS-CoV-2 spike protein
por: Casalino, Lorenzo, et al.
Publicado: (2022)

The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help
por: Inoue, Takeshi, et al.
Publicado: (2017)

Site-specific analysis of the SARS-CoV-2 glycan shield
por: Watanabe, Yasunori, et al.
Publicado: (2020)

Site-specific glycan analysis of the SARS-CoV-2 spike
por: Watanabe, Yasunori, et al.
Publicado: (2020)

Glycan-Based Flow-Through Device for the Detection of SARS-COV-2
por: Baker, Alexander N., et al.
Publicado: (2021)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2023)

Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
por: Kiyoshi, Masato, et al.
Publicado: (2018)

A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
por: Tokunoh, Nagisa, et al.
Publicado: (2023)

Establishment of a highly precise multi-attribute method for the characterization and quality control of therapeutic monoclonal antibodies
por: Tajiri-Tsukada, Michiko, et al.
Publicado: (2020)

Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020)

Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020)

The Effect of Glycans Steric Potentials on Virus Infectivity- the SARS-Cov-2 Case
por: Battaglia, Giuseppe
Publicado: (2021)

The diversity of the glycan shield of sarbecoviruses closely related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ctrjfrm6urnc566m0ai1utll2r